IRIS  Catalogo Istituzionale della Ricerca dell'Università degli Studi del Molise

RINALDI, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.965
EU - Europa 7.420
AS - Asia 3.325
SA - Sud America 1.091
AF - Africa 490
Continente sconosciuto - Info sul continente non disponibili 56
OC - Oceania 7
Totale 22.354
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.609
RU - Federazione Russa 5.476
SG - Singapore 1.534
BR - Brasile 820
IT - Italia 646
CN - Cina 505
FR - Francia 375
CI - Costa d'Avorio 339
VN - Vietnam 323
DE - Germania 276
BD - Bangladesh 199
HK - Hong Kong 195
GB - Regno Unito 186
CA - Canada 172
IN - India 142
AR - Argentina 90
MX - Messico 77
PL - Polonia 70
NL - Olanda 68
IQ - Iraq 58
ZA - Sudafrica 55
TR - Turchia 47
CO - Colombia 41
ID - Indonesia 41
JP - Giappone 40
EC - Ecuador 38
ES - Italia 38
AT - Austria 34
PK - Pakistan 34
CZ - Repubblica Ceca 32
LT - Lituania 32
VE - Venezuela 31
IE - Irlanda 29
SA - Arabia Saudita 29
FI - Finlandia 28
SE - Svezia 27
UA - Ucraina 27
MA - Marocco 26
JM - Giamaica 22
PH - Filippine 22
EG - Egitto 19
UZ - Uzbekistan 19
MY - Malesia 18
CL - Cile 17
AE - Emirati Arabi Uniti 16
HN - Honduras 16
CR - Costa Rica 15
RO - Romania 15
PY - Paraguay 14
UY - Uruguay 14
TH - Thailandia 13
NP - Nepal 12
PE - Perù 12
BO - Bolivia 10
BE - Belgio 9
JO - Giordania 9
TT - Trinidad e Tobago 9
CH - Svizzera 8
NI - Nicaragua 8
AM - Armenia 7
AU - Australia 7
DZ - Algeria 7
EE - Estonia 7
KZ - Kazakistan 7
TN - Tunisia 7
AZ - Azerbaigian 6
BB - Barbados 6
BG - Bulgaria 6
ET - Etiopia 6
GT - Guatemala 6
KE - Kenya 6
KW - Kuwait 6
OM - Oman 6
PR - Porto Rico 6
BY - Bielorussia 5
IL - Israele 5
KR - Corea 5
PA - Panama 5
PT - Portogallo 5
SC - Seychelles 5
SN - Senegal 5
DO - Repubblica Dominicana 4
XK - ???statistics.table.value.countryCode.XK??? 4
AL - Albania 3
BZ - Belize 3
GA - Gabon 3
GY - Guiana 3
HR - Croazia 3
HU - Ungheria 3
LB - Libano 3
LV - Lettonia 3
LY - Libia 3
PS - Palestinian Territory 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BN - Brunei Darussalam 2
CG - Congo 2
Totale 22.271
Salva come PNG Salva come JPEG
Città #
Dallas 2.655
San Jose 1.995
Moscow 1.821
Ashburn 1.017
Singapore 624
The Dalles 370
Abidjan 339
Council Bluffs 335
Lauterbourg 252
New York 214
Hong Kong 188
Beijing 183
Frankfurt am Main 177
Milan 167
Los Angeles 158
Phoenix 156
Santa Clara 138
Ho Chi Minh City 123
Grover Beach 88
São Paulo 83
Seattle 82
Janesville 62
Hanoi 60
Warsaw 59
Chennai 54
Brooklyn 53
Amsterdam 50
Montreal 48
Orem 48
Boardman 47
Miano 47
Denver 46
Plymouth Meeting 44
Chicago 43
Nuremberg 43
Atlanta 41
Toronto 41
London 39
Tokyo 39
Kirkland 34
Assago 30
Boston 30
Munich 30
San Francisco 29
Johannesburg 28
Dublin 27
Princeton 27
Brno 26
Naples 26
Rome 26
Stockholm 26
Rio de Janeiro 25
Brasília 24
Hillsboro 23
Baghdad 22
Mexico City 22
Mumbai 21
Lahore 18
Poplar 18
Tashkent 18
Belo Horizonte 17
Columbus 17
Da Nang 17
Manchester 17
Ankara 16
Buffalo 16
Houston 16
Haiphong 15
Miami 15
West Jordan 14
Campobasso 13
Figino 13
Guarulhos 13
Montevideo 13
Ottawa 13
Querétaro 13
Abbeville 12
Charlotte 12
Curitiba 12
Helsinki 12
Jakarta 12
Kingston 12
Caracas 11
Guayaquil 11
Las Vegas 11
New Delhi 11
Queens 11
Quito 11
Volta Redonda 11
Cape Town 10
Dhaka 10
Falkenstein 10
Goiânia 10
Jeddah 10
Medellín 10
San José 10
Brussels 9
Calgary 9
Casablanca 9
Córdoba 9
Totale 13.052
Salva come PNG Salva come JPEG
Nome #
Impact of Gliflozins on Right Heart Remodeling in Italian Patients with Type 2 Diabetes and Heart Failure: Results from the GLISCAR Real-World Study 627
Metabolic Rewiring of Bacterial Pathogens in Response to Antibiotic Pressure—A Molecular Perspective 551
Assessment of Response and Safety of Bulevirtide Treatment in Patients with Chronic Delta Virus Infection: The ARISTOTLE Pilot Observational Study 182
The impact of new onset diabetes on cardiovascular risks in orthotopic liver transplant recipients: findings from the COLT study 167
Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study 164
A genic and epigenetic combination therapy for liver cancer 153
Advances in the Insulin–Heart Axis: Current Therapies and Future Directions 151
An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors 147
Advances in Nanomedicine for Precision Insulin Delivery 140
Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes 139
Advances in Pharmacological Approaches for Managing Hypercholesterolemia: A Comprehensive Overview of Novel Treatments 139
A suspected infective endocarditis in patients with a history of chronic HCV infection 139
[Inhibitors of intra-cystic secretion: novel therapies in ADPKD (Autosomal Dominant Polycystic Kidney Disease)] 137
Adherence to AISF recommendations for integrated management of hepatocellular carcinoma in a real–world clinical practice 137
Angiogenesis inhibitors for the treatment of hepatocellular carcinoma 137
Antibiotic use and associated factors in a large sample of hospitalised older people 136
Alcohol Consumption and Liver Metabolism in the Era of MASLD: Integrating Nutritional and Pathophysiological Insights 134
A gene and epigenetic combination therapy for liver cancer treatment 133
[Next Generation Sequencing and ADPKD] 132
Diabetic Gastroparesis: Navigating Pathophysiology and Nutritional Interventions 132
Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study 129
Oxidative Stress and Cardiovascular Complications in Type 2 Diabetes: From Pathophysiology to Lifestyle Modifications 129
A Controversial Case of a Double Hepatic Incidentaloma in a Male Patient with Kidney Failure 129
Lenvatinib Is Highly Effective in Patients with Hepatocellular Carcinoma Related to Both Metabolic Dysfunction-Associated Steatohepatitis and Alcoholic Etiology: A Propensity Score Analysis 129
Ruolo patogenetico dell'adiponectina nella steatosi associata ad epatite C 127
. Risk of Hepatocellular Carcinoma after HCV Clearance by Direct-Acting Antivirals Treatment Predictive Factors and Role of Epigenetics 127
Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease 127
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 127
Cardiac Hypertrophy: from Pathophysiological Mechanisms to Heart Failure Development 126
Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications 125
Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options 123
An atypical resentation of a parasitic infection, simulating abdominal expansive mass: a multidisciplinary case report 122
Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes 122
A clear case of portal hypertension: a logical consequence of liver cirrhosis? 121
Metabolic dysfunction-associated steatotic liver disease (MASLD): a systemic disease with a variable natural history and challenging management 121
Effects of metformin in heart failure: From pathophysiological rationale to clinical evidence 120
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 119
Adherence to Barcelona Clinic Liver Cancer guidelines in field-practice: results of Progetto Epatocarcinoma Campania 117
An atypical presentation of a rare parasitic infection of Fasciola hepatica: a multidisciplinary case report. 116
Effects of combination therapy with SGLT2 inhibitors and GLP-1 receptor agonists on CRT response and clinical outcomes in in type 2 diabetes mellitus patients receiving chronic anti-diabetic medications: A multicenter observational study 115
Application and internal validation of lung ultrasound score in COVID-19 setting: The ECOVITA observational study 114
Predictive Value of Fatty Liver Index for Long-Term Cardiovascular Events in Patients Receiving Liver Transplantation: The COLT Study 112
Precision Medicine in Type 2 Diabetes Mellitus: Utility and Limitations 111
CURRENT HEPATOCELLULAR CARCINOMA SYSTEMIC PHARMACOLOGICAL TREATMENT OPTIONS 109
Insulin–Heart Axis: Bridging Physiology to Insulin Resistance 109
Modern Challenges in Type 2 Diabetes: Balancing New Medications with Multifactorial Care 101
Cardiovascular benefits from gliflozins: Effects on endothelial function 96
The Dual Burden: Exploring Cardiovascular Complications in Chronic Kidney Disease 95
What changed in the Italian internal medicine and geriatric wards during the lockdown 94
Neurophysiological assessment of peripheral neuropathy through whole plantar nerve conduction in type 2 diabetes mellitus and healthy control subjects 94
Sodium-Glucose Co-Transporters Family: Current Evidence, Clinical Applications and Perspectives 91
Drug–drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients 88
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) 87
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 85
Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations 85
HCV-related steatosis and risk of atherosclerosis 85
Steatosis is a determinant of fibrosis progression in chronic hepatitis C and is correlated both with body composition and viral factors 84
Efficacy and safety of the sofosbuvir/velpatasvir combination for the treatment of patients with early mild to moderate COVID-19 83
Hepatocellular carcinoma and non alcoholic fatty liver disease; a dangerous liaison 83
GLP-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives 81
The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial 81
Sex-difference of multifactorial intervention on cardiovascular and mortality risk in DKD: post-hoc analysis of a randomised clinical trial 80
Epigenetic and Genetic Keys to Fight HPV-Related Cancers 80
Impact of empagliflozin as add-on to metformin vs metformin continuation on MASLD progression in type 2 diabetes: The IMAGIN Study 80
Gender Differences in the Pathogenesis and Risk Factors of Hepatocellular Carcinoma 80
Multidrug-Resistant Infections and Metabolic Syndrome: An Overlooked Bidirectional Relationship 80
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study 80
Late Hepatocellular Carcinoma Occurrence in Patients Achieving Sustained Virological Response After Direct-Acting Antiviral Therapy: A Matter of Follow-Up or Something Else? 78
Features of microvessel density (MVD) and angiogenesis inhibitors in therapeutic approach of hepatocellular carcinoma (HCC) 78
Liver fibrosis by FibroScan is highly prevalent in type 2 diabetic patients with NAFLD and fairly normal liver enzymes but increased uric acid 78
Pathophysiological mechanisms and clinical evidence of relationship between Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease 77
Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options 77
The importance of the thick ascending limb of Henle's loop in renal physiology and pathophysiology 77
HBV Infection and Host Interactions: The Role in Viral Persistence and Oncogenesis 77
Cryptogenic cirrhosis is associated with cardiometabolic and oncologic comorbidities and poor liver-related prognosis 77
Twelve-week course of pIFN-a-2a/ribavirin is an optimized regimen for treatment of HCV genotype 2 but not genotype 3 non-cirrhotic patients with RVR 77
The Diabetic Cardiomyopathy: The Contributing Pathophysiological Mechanisms 76
Sonoporation by microbubbles as gene therapy approach for liver cancer 76
Non-invasive respiratory support in SARS-CoV-2 related acute respiratory distress syndrome: when is it most appropriate to start treatment? 76
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study 75
Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic Strategies 75
Role of tight glycemic control during acute coronary syndrome on CV outcome in type 2 diabetes 74
Insulin resistance and cancer: molecular links and clinical perspectives 74
IMPACT OF TYPE II DIABETES ON HCC APPEARANCE IN PATIENTS TREATED WITH DIRECT ACTING ANTIVIRALS 74
FibroScan Identifies Patients With Nonalcoholic Fatty Liver Disease and Cardiovascular Damage 74
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 73
NAFLD fibrosis score (NFS) can be used in outpatient services to identify chronic vascular complications besides advanced liver fibrosis in type 2 diabetes 73
Early changes of liver stiffness in HCV patients undergoing treatment with direct-acting antivirals (DDAs): a multicenter study 73
Influence of antiviral therapy on the liver stiffness in chronic HBV hepatitis 73
The Intestinal Thread of Fate: How the Microbiota Shapes the Story of Liver Disease 73
Neoadjuvant and Adjuvant Systemic Therapies in Loco-Regional Treatments for Hepatocellular Carcinoma: Are We at the Dawn of a New Era? 73
Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study 72
Nonalcoholic fatty liver disease: Evolving paradigms 72
Late HCC onset after direct antiviral agents therapy in patients with sustained virological response: do we need to reconsider their efficacy according to long term follow-up? 72
Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy 72
Influence of antiviral therapy on liver stiffness evaluation in chronic hepatitis HBV patients in a real world setting: preliminary data in a multicentric study 71
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 71
The Role of Lung Ultrasound in SARS-CoV-19 Pneumonia Management 71
Impact of SGLT2 Inhibitors on Heart Failure: From Pathophysiology to Clinical Effects 71
Chronic hepatitis C, atherosclerosis and cardiovascular disease: What impact of direct-acting antiviral treatments? 70
Totale 11.146
Salva come PNG Salva come JPEG
Categoria #
all - tutte 98.436
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 98.436
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024334 0 0 0 0 2 151 11 44 5 17 20 84
2024/20253.369 520 223 254 23 416 66 112 121 453 74 490 617
2025/202615.447 530 1.404 1.774 735 3.353 3.104 1.682 639 508 1.157 419 142
2026/20273.204 303 606 1.133 1.162 0 0 0 0 0 0 0 0
Totale 22.354